EUVIMEDEUVIMED entdecken
Open Access

Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care System

Jennifer La, Tammy Hshieh, Anahid Hamparsumian, Robert Zwolinski, Jameson Wood, Mayuri Dharne, J Michael Gaziano, Mary T Brophy, Nhan V Do, Nikhil C Munshi, Jane A Driver, Gregory A Abel und 2 weitere

Journal of the National Comprehensive Cancer Network · 2025

DOI: 10.6004/jnccn.2025.7051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025. Verfasst von Jennifer La und 13 weiteren Autor:innen. Beteiligte Einrichtung: 1Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Neoplasms, Frailty, Potentially Inappropriate Medication List. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, CSRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies have operationalized the NCCN list of high-risk medications in older adults into a measurable tool known as the Geriatric Oncology Potentially Inappropriate Medications (GO-PIMs) scale. The current study aims to evaluate the ability of GO-PIMs to identify high-risk medications and their impact on patients with both solid and liquid tumors managed in a large national health care system.

Methods

We performed a retrospective cohort study using data from the national Veterans Affairs (VA) Cancer Registry and electronic health records, including all veterans newly diagnosed with a solid or liquid malignancy from 2000 to 2022. The number of GO-PIMs for each patient was determined from outpatient pharmacy prescriptions filled in the 90 days preceding the initial cancer diagnosis (the index date). We assessed the association of PIMs with baseline frailty—measured using the electronic Veterans Affairs Frailty Index (VA-FI) and categorized as nonfrail (≤0.2), mildly frail (>0.2–0.3), or moderate-to-severely frail (>0.3)—and with unplanned hospitalization and mortality during follow-up, using multivariable models adjusted for age, gender, cancer type and stage, Charlson comorbidity index score, and socioeconomic factors.

Results

Among 388,113 patients with newly diagnosed cancer (median age, 69.3 years [IQR, 62.8–76.7]; most common cancer types: prostate [21.5%], lung [23.7%], and gastrointestinal [20.5%]), GO-PIMs were prevalent, with 38% patients receiving ≥1 GO-PIM. Each additional GO-PIM was associated with a 66% increase in the odds of being mildly or moderate-to-severely frail at diagnosis, after adjusting for all covariates (ordinal regression adjusted odds ratio, 1.66; 95% CI, 1.65–1.67). Each additional GO-PIM was also associated with a higher hazard of unplanned hospitalization (Cox regression adjusted hazard ratio [aHR], 1.08; 95% CI, 1.07–1.08) and death (Cox regression aHR, 1.07; 95% CI, 1.06–1.07), after adjusting for frailty and all covariates.

Conclusions

An increasing number of PIMs, as identified by the GO-PIMs scale, was independently associated with greater risk of frailty at diagnosis, unplanned hospitalization during follow-up, and mortality among patients treated within a large national health care system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsFrailtyPotentially Inappropriate Medication ListHumansMaleFemaleAgedRetrospective StudiesUnited StatesAged, 80 and overUnited States Department of Veterans AffairsMiddle Aged

Autor:innen und Institutionen

  • 1Harvard Medical School, Boston, MA.
  • 2VA Boston Cooperative Studies Program Center, MAVERIC, Boston, MA.
  • 3Dana-Farber Cancer Institute, Boston, MA.
  • 4Brigham and Women's Hospital, Boston, MA.
  • 5Hebrew SeniorLife and Marcus Institute for Aging Research, Boston, MA.
  • 6Duke University, Durham Health System, Durham, NC.

Förderung

  • BLRD VA
  • CSRD VA

Zitieren

APA

La, J., Hshieh, T., Hamparsumian, A., Zwolinski, R., Wood, J., Dharne, M., Gaziano, J. M., Brophy, M. T., Do, N. V., Munshi, N. C., Driver, J. A., Abel, G. A., Fillmore, N. R., & DuMontier, C. (2025). Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care System. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2025.7051

Vancouver

La J, Hshieh T, Hamparsumian A, Zwolinski R, Wood J, Dharne M, et al. Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care System. Journal of the National Comprehensive Cancer Network. 2025. doi:10.6004/jnccn.2025.7051

BibTeX
@article{La2025,
  author = {La, Jennifer and Hshieh, Tammy and Hamparsumian, Anahid and Zwolinski, Robert and Wood, Jameson and Dharne, Mayuri and Gaziano, J Michael and Brophy, Mary T and Do, Nhan V and Munshi, Nikhil C and Driver, Jane A and Abel, Gregory A and Fillmore, Nathanael R and DuMontier, Clark},
  title = {Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care System},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2025},
  doi = {10.6004/jnccn.2025.7051}
}
Kostenlos starten →